Portuguese patch testing finds many chronic hand eczema cases link to allergic contact dermatitis—especially occupational exposures like methylisothiazolinone, HEMA acrylates, thiuram mix, nickel.
|Articles|November 14, 2011
NCQA to Start Accrediting ACOs this Month
Advertisement
The National Committee for Quality Assurance (NCQA), an accreditation and certification not-for-profit, will accredit accountable care organizations (ACOs) starting later this month. Officials are expected to discuss the accreditation at a briefing on November 14.
Margaret O'Kane, president of the NCQA, said accountable care furthers healthcare delivery reform efforts that began with the patient-centered medical home. The NCQA certifies patient-centered medical homes.
.
The NCQA ACO accredition will focus on seven domains. Read the details at
For the full news story, visit:
Sources: Modern Healthcare; NCQA
Advertisement
Related to this article
Two posters report 3.9% first-year GLP-1 discontinuation and a 5-day median time to first fill under pharmacist-led care.
CDC's Jane Henley, MSPH, explains what's behind falling lung cancer deaths and why 4 in 5 eligible adults still aren't getting screened.
The regulatory decisions reflect how advances in biomarkers and molecular medicine are reshaping both diagnosis and treatment.
As peptides go mainstream, the FDA's shifting rules and a fractured state patchwork leave patients navigating a largely unregulated gray market.
Community oncologists cited prior authorization as a care barrier, even as AI adoption doubled in 2026, according to the Oncology Care Index.
A large propensity-matched study linked outpatient melatonin use to a small reduction in REM sleep in children evaluated for polysomnography.
Prior authorization and compounded drugs remain top obesity care access barriers, says NYU Langone's Holly Lofton, MD.
Advertisement
Advertisement
Trending on AJMC
1
NCCN Journal Publishes Guidelines Update in Mantle Cell Lymphoma
2
Peptide Regulation Debate Intensifies After FDA Advisory Panel's Controversial Vote
3
Switching to Subcutaneous Ocrelizumab for MS Could Free 883 Chair Hours in a Year
4
Health System Pharmacies Keep Patients on GLP-1 Therapy
5